|
Centre for Policy on Ageing | |
 | |
|
Trends in the treatment of osteoporosis and types of drug treatments prescribed in general practice in England and Wales, 1994 to 1998 | Author(s) | Katie Bailey, Charlotte Ellis, Azeem Majeed |
Journal title | Health Statistics Quarterly, no 16, Winter 2002 |
Pages | pp 5-13 |
Keywords | Osteoporosis ; Therapy ; Drugs ; General practice ; Longitudinal surveys ; England ; Wales. |
Annotation | Data from 210 general practices contributing to the General Practice Research Database (GPRD) indicates that the age-standardised treatment rate (treated prevalence) of osteoporosis rose from 3.6 to 7.2 per 1,000 females and from 0.4 to 0.9 per 1,000 males between 1994 and 1998. Biophosphonates were the most commonly prescribed drugs, used in 59% of female and 77% of male patients in 1998. The percentage of osteoporosis patients prescribed biophosphonates and vitamin D increased over time. In contrast, prescribing of hormone replacement therapy (HRT) remained stable, and calcium-prescribing rates fell. The treated prevalence of osteoporosis was substantially lower than estimates from surveys. This suggests that most people with osteoporosis are not identified or prescribed drug treatments by GPs. (RH). |
Accession Number | CPA-021216217 A |
Classmark | CLO: LO: LLD: L5: 3J: 82: 9 |
Data © Centre for Policy on Ageing |
|
...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|